跳至主要内容
临床试验/NCT01548872
NCT01548872Unknown4 期

Comparison of the Effects of Crystalloid Cardioplegia and HTK Solution for Postoperative Troponin-I and CK-MB Levels After Pediatric Cardiac Surgery

Baskent University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2011年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
60
试验地点
1
主要终点
myocardial protective effect of HTK solution

研究概览

简要总结

The purpose of this study is to compare two different cardioplegia solutions effect on postoperative Troponin-I and CK-MB levels after pediatric cardiac surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
1 Month 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Patients scheduled for elective pediatric cardiac surgery
  • Patients written informed consent for study participation

排除标准

  • redo surgery
  • allergy to study drugs
  • unstable blood pressure before cardiac surgery

研究组 & 干预措施

crystalloid cardioplegia solution

Active Comparator

After aortic cross clamp 30ml/kg will be administered

干预措施: crystalloid cardioplegia solution (Drug)

HTK solution

Active Comparator

After aortic cross clamp 50ml/kg will be administered

干预措施: HTK solution (Drug)

结局指标

主要结局

myocardial protective effect of HTK solution

时间窗: postoperative 48 hours

to detect %33 difference in Troponin-I levels 4 hours postoperatively

次要结局

  • hemodynamic and respiratory data(postoperative 48 hours)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Selim Kuslu

Anesthesiology Resident

Baskent University

研究点 (1)

Loading locations...

相似试验